Abridge

Sacra estimates that Abridge hit $100M in ARR in May 2025, up from $60M at the end of 2024. This growth trajectory reflects the company's transition from pilot programs to full enterprise deployments across major health systems, with contracted ARR reaching $117M in Q1 2025.

The revenue model centers on enterprise subscription licenses priced at approximately $2,500 per clinician per year, positioning Abridge between lower-cost competitors like Nabla at $119 per month and premium offerings like Nuance DAX Copilot at $600 per month.

Major customers driving this growth include Kaiser Permanente with rollouts to 24,600 physicians across 40 hospitals and 600 clinics, Mayo Clinic with enterprise-wide deployment to over 2,000 physicians plus nursing pilots, and health systems like Johns Hopkins, Duke Health, UPMC, and Yale New Haven among more than 90 publicly disclosed customers.

Abridge is valued at $5.3B following its $300M Series E round led by Andreessen Horowitz announced in June 2025, representing a 93% jump from its $2.75B valuation just four months earlier. This 53x revenue multiple reflects the company's dominant position as Epic's closest AI scribe partner.

Key investors include prominent healthcare and tech funds such as Lightspeed Venture Partners, Bessemer Venture Partners, Redpoint, Spark Capital, Kaiser Permanente Ventures, CVS Health Ventures, the California Health Care Foundation, and NVIDIA's venture arm NVentures.

Abridge transforms doctor-patient conversations into structured clinical documentation through an AI system designed specifically for medical dialogues. During a patient visit, a clinician activates the Abridge app on their mobile device or computer (or through the EHR if integrated). The system records the conversation and within minutes produces a complete medical note in SOAP format (Subjective, Objective, Assessment, Plan).

What distinguishes Abridge is its "Linked Evidence" feature, which connects each line in the generated note back to the specific point in the conversation where it was discussed. This allows doctors to quickly verify the accuracy of the AI's work by clicking on any part of the note to hear the relevant audio.

The system is fine-tuned for medical terminology through custom speech recognition models and can handle 14 different languages, including scenarios with interpreters present.

For a physician, the workflow is straightforward: they conduct their visit naturally, focusing entirely on the patient rather than typing notes. Once the conversation ends, Abridge delivers a structured note directly into the patient's electronic chart. The doctor reviews the AI-generated content, makes any necessary edits, and signs off—a process that reportedly saves practitioners up to 3 hours of documentation time per day compared to manual entry.

Abridge has evolved from a standalone app to an enterprise platform deeply integrated into hospital systems. In 2023, it became the first ambient AI tool officially integrated into Epic's EHR through the "Pal" program, allowing physicians to launch Abridge directly within their existing workflow. The company has also developed a "Contextual Reasoning Engine" that incorporates patient history, doctor preferences, and hospital billing guidelines to create notes that are not just accurate transcripts but clinically useful summaries that meet coding requirements essential for proper reimbursement.

The platform has since extended well beyond outpatient documentation into active clinical workflow management. Abridge Inside for Inpatient brings the same ambient AI capabilities into hospital inpatient settings, while Outpatient Orders inside Epic allows clinicians to place orders directly from within the Abridge workflow rather than switching back to the EHR. The platform also supports real-time prior authorization at the point of conversation—developed initially with Highmark Health and Allegheny Health Network's 14 hospitals—with a deeper integration built alongside Availity that routes conversational intelligence directly into payer systems, closing the loop between clinical documentation and insurance approval without a separate administrative step.

Abridge operates a B2B SaaS model, selling enterprise licenses directly to healthcare provider organizations rather than to individual clinicians.

Their pricing scales with deployment size—typically based on either the number of physician users or the volume of patient encounters processed—and varies according to the complexity of integration required at each site.

The company's go-to-market strategy has evolved from an initial focus on gathering data through a free consumer-facing app to an enterprise sales motion targeting large health systems.

Abridge's primary go-to-market advantage stems from giving Epic both an equity stake and ongoing revenue share, securing preferential access to 38% of all hospital networks that use Epic.

This partnership keeps Abridge 3-6 months ahead of competitors like Nabla and Ambience on integration depth, positioning them as the default AI scribe in Epic-owned systems like Mayo, Kaiser, and Duke. However, this arrangement limits Abridge's degrees of freedom when it comes to disrupting Epic itself, constraining their ability to compete in EHR modules like patient portals or scheduling.

The top-down enterprise market is dominated by Nuance's Dragon Ambient eXperience (DAX), acquired by Microsoft for $19.7B.

As the longtime leader in medical speech recognition with Dragon Medical, Nuance leverages Microsoft's resources and GPT-4 integration to enhance its offerings. Like Abridge, Nuance has secured tight integration with Epic, creating a competitive dynamic where health systems often evaluate these two options head-to-head.

Abridge has managed to differentiate by developing a fully automated approach that delivers notes faster than Nuance's DAX, which historically relied on human transcriptionists in its workflow. However, Microsoft's backing gives Nuance enormous resources to close any technology gap, making this a challenging competitive segment.

Freed ($20M ARR) and Heidi Health ($15M raised) represent a different approach, attacking the market bottom-up through product-led growth targeting individual physicians and small practices. They offer significantly lower price points ($99/month versus Abridge's enterprise pricing of $300-600/month) that appeal to the 47% of U.S. clinicians working in small practices with fewer than 10 doctors.

These competitors avoid the long enterprise sales cycles by targeting doctors who are both users and decision-makers. Freed has demonstrated remarkable efficiency, reaching $13M ARR with just four salespeople. While they lack Abridge's deep EHR integration and enterprise features, their capital efficiency and rapid growth pose a different kind of threat, potentially commoditizing basic documentation functions.

A third competitive category includes specialized AI documentation startups targeting specific niches. Nabla, based in France, has demonstrated success with Kaiser Permanente in Northern California. DeepScribe focuses on smaller clinics with a lower-cost alternative that combines AI with human quality checks.

Augmedix, originally launched using Google Glass for remote human scribes, was acquired by Commure for $139M, demonstrating the consolidation happening in this space. Ambience Healthcare and other newer entrants continue to emerge, fragmenting the market and potentially focusing on specialty-specific workflows that Abridge might not address as comprehensively.

KLAS has named Abridge #1 Best in KLAS for Ambient AI in Revenue Cycle Management for two consecutive years, most recently in February 2026, with A+ ratings across Culture, Loyalty, Relationship, and Value. Enterprise buying committees at health systems routinely use KLAS rankings as a primary procurement filter, making back-to-back top rankings a durable competitive moat against both incumbent and emerging rivals.

Abridge's initial focus on outpatient ambulatory visits represents just one segment of the broader healthcare documentation market. The platform now extends into hospital inpatient settings through Abridge Inside for Inpatient, with UPMC's commitment to scale Abridge to 12,000+ clinicians across 40+ hospitals and 800 outpatient sites by 2026 representing the first large proof point of multi-setting enterprise deployment.

Documentation workflows vary dramatically between specialties—cardiac surgery differs from radiology, which differs from mental health. Seattle Children's selection of Abridge following a 90-day pilot across 18 pediatric specialties, which produced a 79% average reduction in documentation effort across 72% of eligible encounters, establishes pediatrics as a validated specialty wedge with replicable deployment methodology.

Moving beyond basic note transcription into broader administrative workflows represents another significant TAM expansion opportunity. Abridge's Outpatient Orders integration inside Epic, combined with real-time prior authorization through the Highmark and Availity partnerships, demonstrates that the platform is already executing on this vector—bridging clinical conversation directly to orders, coding, and insurance workflows within the $250B+ U.S. revenue cycle market. By automating more of the administrative burden beyond note-taking—including orders, diagnosis coding, and billing documentation—Abridge can significantly increase its per-user revenue potential and expand the total addressable contract value per health system.

Abridge initially focused on physicians, but healthcare documentation extends to numerous other provider types. Nurses, physician assistants, therapists, mental health providers, and various specialists all face documentation burdens that could be addressed by Abridge's technology. UCHealth's deployment, where more than one-third of its ~6,000 doctors, nurse practitioners, and physician assistants were already active users as of February 2026, illustrates how contracts naturally expand beyond physicians once a system deploys.

Rural health systems represent an additional vector: WVU Medicine's deployment to 2,800+ clinicians across 25 hospitals—where surveyed clinicians reported 78% more undivided attention to patients and 77% higher work satisfaction—demonstrates that smaller, geographically dispersed systems are viable and scalable customers alongside major academic medical centers.

EHR commoditization: As the dominant EHR vendors like Epic and Cerner continue to evolve their platforms, they may decide to build or acquire their own ambient documentation capabilities, rendering third-party solutions like Abridge redundant. While Abridge has secured a partnership with Epic, this relationship involves "selling the farm" with significant equity and revenue share arrangements that could limit Abridge's autonomy and ability to disrupt the status quo.

Bottom-up competition pressure: The success of lower-cost, bottom-up players like Freed ($99/month) targeting individual physicians and small practices could commoditize basic documentation functionality, forcing enterprise-focused vendors like Abridge to continually justify their premium pricing.

Integration complexity ceiling: The healthcare integration landscape remains highly fragmented with thousands of data formats across different EHR systems and specialties. This creates a ceiling on how many integration points Abridge can feasibly maintain at high quality, potentially limiting market reach beyond major systems like Epic. Unlike horizontal SaaS products, healthcare solutions face unique middleware challenges where "a generalized API fails" to solve the deep integration needs of clinical documentation workflows.